Noopept (omberacetam): dosage in studies

Not a recommendation, not treatment guidance. This page shows only what published human studies used, with sources. This site does not say how much anyone should use of any substance. Fimea warns against using injectable peptides bought online: Fimea warning.

Noopept is in Annex 1 A of Fimea's medicines list, so in Finland it is always treated like a prescription-only medicine [3]regulator.

Two small Russian human studies report the Noopept dose in their abstracts, in milligrams per day [1, 2]B.

Doses used in studies

Doses used in published human studies. Not a recommendation.
StudyParticipantsDoseFrequencyDurationSource and level
Amelin 2011 (open, control group) 60 stroke patients with mild cognitive impairment 20 mg a day; route not stated in the abstract Daily 2 months [1]B
Mordyk 2009 (two groups, no placebo) 60 tuberculosis patients, 30 of whom received Noopept 10 mg; route not stated in the abstract Twice a day First month of treatment [2]B

Evidence levels: regulator = a regulator's assessment or decision, not research evidence · A = randomised human trial or meta-analysis · B = observational human study or case series · C = animal study · D = cell or laboratory study · E = not peer-reviewed

Notes

Neither study was placebo-controlled, and both were published in Russian-language journals of which only the English abstract is available [1, 2]B.

What points the other way or is uncertain

The comparative study of Noopept and piracetam has no published abstract, so its doses and results are not shown here [4]B.

More on this

Read the research yourself: sources

  1. Amelin AV, Iliukhina AIu, Shmonin AA. [Noopept in the treatment of mild cognitive impairment in patients with stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(10 Pt 1):44-46. In Russian, English abstract. PMID 22500312
  2. Mordyk AV, Lysov AV, Kondria AV, et al. [Prevention of neuro- and cardiotoxic side effects of tuberculosis chemotherapy with noopept]. Klin Med (Mosk). 2009;87(5):59-62. In Russian, English abstract. PMID 19565831
  3. Finland. Lääkeluettelo (Fimea medicines list), 230/2025, section 2 and annex 1 A ("Noopept"). Finlex
  4. Neznamov GG, Teleshova ES. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin. Neurosci Behav Physiol. 2009;39(3):311-321. No abstract. PMID 19234797

Doses are from the English abstracts of the sources, read 15 Oct 2026.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.